Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2026-01-05 @ 5:17 PM
Study NCT ID:
NCT05287568
Status:
RECRUITING
Last Update Posted:
2025-01-03
First Post:
2022-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CC-486 and Venetoclax for Acute Myeloid Leukemia
Sponsor:
University of Colorado, Denver
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-09
First Submit QC Date:
None
Study First Post Date:
2022-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-02
Last Update Post Date:
2025-01-03
Last Update Post Date Type:
ACTUAL